Robert V. P. Martinez

机构：Pfizer (United States)

发表论文 29 篇 · 总被引 1189 次 · h-index 15

代表论文

• A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer (2003 · Cell · 被引 420)
• Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems (2020 · Cellular and Molecular Gastroenterology and Hepatology · 被引 95)
• Inhibition of Gluconeogenesis through Transcriptional Activation of EGR1 and DUSP4 by AMP-activated Kinase (2006 · Journal of Biological Chemistry · 被引 82)
• Slug (SNAI2) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma Preclinical Models (2008 · Clinical Cancer Research · 被引 68)
• LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells (2009 · American Journal of Physiology-Cell Physiology · 被引 67)
• Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH) (2019 · PLoS ONE · 被引 65)